Pereira Ana, Garmendia Maria Luisa, Uauy Ricardo, Neira Paulina, Lopez-Arana Sandra, Malkov Serghei, Shepherd John
Institute of Nutrition and Food Technology, University of Chile, Av. El Líbano 5524, Macúl, Santiago, 7830490, Chile.
Pediatrics Division, School of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile.
Breast Cancer Res Treat. 2017 Apr;162(2):343-352. doi: 10.1007/s10549-017-4126-7. Epub 2017 Jan 28.
PURPOSE: High mammographic breast density (BD) is a strong risk factor of breast cancer; however, little is known in women under 40 years of age. Recently, dual-energy X-ray Absorptiometry (DXA) has been developed as a low-dose method to measure BD in young populations. Thus, our aims were to describe BD in relation to risk factors in Chilean women under 40 years old and to explore the equivalence of DXA to mammography for the measurement of BD. METHODS: We selected 192 premenopausal Chilean female participants of the DERCAM study for whom we have anthropometric, sociodemographic, and gyneco-obstetric data. The subjects received both digital mammograms (Hologic) and breast DXA scans (GE iDXA). Mammographic BD was estimated using a fully automated commercial method (VOLPARA) and BI-RADS. Breast DXA scans were performed using a standardized protocol and the % fibroglandular volume (%FGV) was estimated considering a two-compartment model of adipose and fibroglandular tissue. RESULTS: The mean age was 37 years (SD = 6.5) and 31.6% of the subjects were obese. The median %FGV and absolute FGV (AFGV) measured by DXA were 9% and 198.1 cm and for VOLPARA, 8.6% and 58.0 cm, respectively. The precision for %FGV after reposition was 2.8%. The correlation coefficients for %FGV, AFGV, and breast volume between DXA and mammography were over 0.7. Age and body mass index (BMI) were inversely associated with %FGV, and BMI was positively related to AFGV as estimated with DXA or mammography. We did not observe an association with gyneco-obstetric characteristics, education, and %FGV and AFGV; smoking was only associated with AFGV as measured by VOLPARA. CONCLUSIONS: DXA is an alternative method to measure volumetric BD; thus, it could be used to continuously monitor BD in adult women in follow-up studies or to assess BD in young women.
目的:乳腺钼靶高密度(BD)是乳腺癌的一个重要危险因素;然而,对于40岁以下的女性,人们了解甚少。最近,双能X线吸收法(DXA)已被开发为一种在年轻人群中测量BD的低剂量方法。因此,我们的目的是描述智利40岁以下女性BD与危险因素的关系,并探讨DXA与乳腺钼靶在测量BD方面的等效性。 方法:我们从DERCAM研究中选取了192名绝经前智利女性参与者,我们掌握她们的人体测量学、社会人口统计学和妇产科数据。这些受试者接受了数字化乳腺钼靶检查(Hologic)和乳腺DXA扫描(GE iDXA)。使用全自动商业方法(VOLPARA)和BI-RADS评估乳腺钼靶BD。乳腺DXA扫描按照标准化方案进行,并根据脂肪和纤维腺组织的两室模型估计纤维腺体积百分比(%FGV)。 结果:平均年龄为37岁(标准差=6.5),31.6%的受试者肥胖。DXA测量的%FGV中位数和绝对纤维腺体积(AFGV)分别为9%和198.1 cm,VOLPARA测量的分别为8.6%和58.0 cm。重新定位后%FGV的精度为2.8%。DXA与乳腺钼靶之间%FGV、AFGV和乳房体积的相关系数超过0.7。年龄和体重指数(BMI)与%FGV呈负相关,BMI与DXA或乳腺钼靶估计的AFGV呈正相关。我们未观察到妇产科特征、教育程度与%FGV和AFGV之间的关联;吸烟仅与VOLPARA测量的AFGV相关。 结论:DXA是测量体积性BD的一种替代方法;因此,它可用于在随访研究中持续监测成年女性的BD或评估年轻女性的BD。
Breast Cancer Res Treat. 2017-4
Breast Cancer Res. 2024-3-12
Br J Cancer. 2023-5
Breast Cancer Res Treat. 2024-6
Breast Cancer Res Treat. 2024-6
Breast Cancer Res. 2024-3-12
Br J Cancer. 2023-5
Curr Environ Health Rep. 2022-12
Front Public Health. 2022
Cancer Epidemiol Biomarkers Prev. 2022-7-1